# AMERICAN PUBLIC EDUCATION INC (APEI) — Financial Analysis

**Exchange:** Nasdaq  
**Coverage as of:** 2026-Q2  
**Updated:** 2026-06-17  
**Tier:** Free primer (step 2 of 19)  
**Sibling pages:** /stocks/apei/thesis · /memo/apei

## Financial Snapshot

---
source: coverage-next-full
step: 04
ticker: APEI
title: Financial Quality & Adversarial Sweep
date: 2026-06-15
---

### APEI — Step 04: Financial Quality & Adversarial Sweep

#### 1. Statement Quality Assessment

##### Revenue Recognition
- APEI recognizes tuition revenue ratably over the academic term per ASC 606 [S1]
- Standard "tuition received/receivable" model — low complexity; limited deferral manipulation risk
- Refund policy: Title IV return calculations (R2T4) reduce net revenue when students withdraw — properly reflected in results
- **Quality: HIGH** — tuition revenue recognition is straightforward and well-audited

##### Goodwill and Intangibles
- Rasmussen acquisition (Dec 2021, ~$193M) created significant goodwill that was subsequently impaired:
  - FY2022: ~$141M goodwill impairment charge (Q2 2022)
  - FY2023: ~$72M additional impairment charges (Q2 2023)
  - FY2025 balance sheet: Total assets $521M down from $725M at acquisition close — reflects ~$200M+ in impairment-driven asset reduction
- **Assessment:** The impairments appear appropriately triggered by enrollment shortfalls; remaining goodwill/intangibles have been stress-tested. Risk of further impairment is lower now that enrollment is stabilizing and growing [S1]

##### Cash Flow Quality [S2]
| Metric | FY2023 | FY2024 | FY2025 | TTM |
|--------|--------|--------|--------|-----|
| Net Income | $(47.3M) | $16.1M | $31.6M | $40.4M |
| Operating CF | $45.5M | $48.9M | $62.0M | $88.3M |
| CF/NI Conversion | NM | 3.0x | 2.0x | 2.2x |
| FCF | $31.6M | $27.8M | $46.1M | $73.8M |

**Assessment:** Operating cash flow consistently exceeds GAAP net income — the CF/NI ratio >1.0x is a positive quality signal. The delta is explained by (a) non-cash D&A running $16–32M/year, (b) non-cash SBC ~$8M/year, and (c) modest working capital. FCF is real and growing.

##### Working Capital
- Accounts receivable is primarily student tuition receivable (Title IV disbursements, DoD TA payments)
- Receivables grew slightly in FY2025 ($5.3M increase) — consistent with revenue growth
- Deferred revenue (unearned tuition) is small relative to revenue given short academic terms (8-10 weeks)
- **Quality: HIGH** — no unusual AR build or deferred revenue concerns

##### SBC
- Stock-Based Compensation: ~$8.4M (FY2025), ~1.3% of revenue — modest; not dilutive at material scale [S2]
- Diluted share count: ~18–19M shares; minimal dilution trend

##### Adjusted Metrics Review
- Company presents "Adjusted EBITDA" which adds back SBC ($8.4M), D&A ($16.2M), goodwill impairments (now zero), restructuring charges
- FY2025 reported Adjusted EBITDA: $85.7M (13.2% adj. EBITDA margin) — per investor day presentation [S3]
- **Assessment:** Adjustments appear reasonable; no aggressive add-backs flagged. SBC is legitimately non-cash. D&A is genuinely declining (acquisition intangibles amortizing off)

---

#### 2. Adversarial Research Sweep

##### Short Seller / Critical Reports
| Source | Date | Claim | Status |
|--------|------|-------|--------|
| High short interest (14% of float) | Ongoing 2026 | Short thesis unclear publicly; elevated shorting suggests skepticism about earnings quality, regulatory risk, or valuation | Active — see below |
| Historical sector stigma | 2015–2020 | For-profit education sector faced DOE/CFPB scrutiny post-Corinthian/ITT failures | APEI survived; not in same risk category |

**Short Interest Analysis:** 14% of float short (~2.4M shares, 5-day cover ratio) is elevated and up ~260% YoY. The probable short thesis involves: (1) 90/10 Rule regulatory risk if APUS federal revenue buffer tightens further, (2) skepticism that the HLC consolidation executes on schedule, (3) earnings quality concerns (GAAP EPS still modest at $1.36 despite $85.7M adj. EBITDA — implying ~$50M+ in "adjustments" between them), and/or (4) activist overhang as 325 Capital exits.

**Assessment:** The short interest level is a legitimate signal to investigate. However, GAAP FCF ($46.1M FY2025) is real and improving, cash is building, and no fraud indicators appear in filings.

##### Regulatory/Legal Actions
| Action | Status | Impact |
|--------|--------|--------|
| 90/10 compliance (APUS ~89%) | Ongoing compliance risk | No current violation; tightly monitored |
| Borrower Defense claims | Minimal for APEI scale | Not a material financial exposure vs. sector |
| Gainful Employment rule | GE rule vacated by courts; Trump admin not reinstating | Regulatory risk reduced |
| HLC reviews | Ongoing — HLC approved consolidation May 2026 | Positive resolution |
| State regulatory (nursing) | Standard ACEN/BON oversight | No unusual issues |

##### Lawsuits and Investigations
- No material lawsuits or regulatory investigations disclosed in recent 10-K beyond standard boilerplate litigation reserves [S1]
- The sector has faced class action suits (enrollment misrepresentation) at ITT/Corinthian era schools; APEI does not appear in the same category

##### Accounting Red Flags Assessment
| Check | Result |
|-------|--------|
| Revenue recognition | Clean — ASC 606 ratable recognition |
| Earnings vs. cash flow divergence | Positive divergence (CF > NI) |
| Unusual related-party transactions | None identified |
| Auditor changes | Grant Thornton — consistent auditor; no recent change |
| Internal control weaknesses | No material weaknesses disclosed |
| Aggressive goodwill management | Impairments were timely and large — if anything, over-impaired |

---

#### 3. Financial Quality Summary

| Dimension | Grade | Notes |
|-----------|-------|-------|
| Revenue quality | A | Tuition revenue, clean recognition, no channel stuffing |
| Earnings quality | B+ | GAAP EPS modest vs. adj. EBITDA; difference is non-cash D&A + SBC |
| Cash flow quality | A | OCF consistently > NI; FCF growing |
| Balance sheet quality | B+ | Net cash now positive; minimal off-balance-sheet risk |
| Accounting conservatism | A | Large impairments taken proactively; no aggressive add-back inflation |
| Regulatory risk | C+ | 90/10 buffer is thin; Title IV dependency is structural |
| Litigation risk | B | Sector background risk; no company-specific exposure flagged |

**Overall Financial Quality: B+ / Good** — Real cash generation, clean accounting, but regulatory concentration is a genuine structural risk that warrants a valuation discount vs. non-reliant peers.

---

#### Source Index
[S1] SEC 10-K FY2025 — Audited financial statements, risk factors, goodwill impairment disclosures (CIK 0001201792)
[S2] StockAnalysis.com — Annual income statement and cash flow (2026-06-15)
[S3] APEI Investor Day November 2025 — Adjusted EBITDA disclosure (from investor presentation summary)

## Deeper Financial Analysis

The fundamental tier ($1.00) adds 8 dimensions not included here:

- Revenue Breakdown — segment revenue, geographic mix, product-line margins
- Financial Trends — QoQ momentum, leading indicators, inflection points
- Balance Sheet — debt structure, dilution risk, working capital dynamics
- Capital Allocation — ROIC, buyback cadence, reinvestment efficiency
- Earnings Analysis — beats/misses, guidance vs actuals, transcript highlights
- Competitive Positioning — market share, pricing power, peer benchmarks
- Industry Context — TAM, sector tailwinds/headwinds, regulatory backdrop

**API endpoint:** GET /api/v1/research/APEI/fundamental

## Navigation

- Overview: /stocks/apei
- Financials (this page): /stocks/apei/financials
- Thesis: /stocks/apei/thesis
- Investment Memo: /memo/apei
- Coverage universe: /stocks